Abdul-Aziz, N., N. Abdulhameed, A. Marellapudi, and H. Shah. “Multiple Sclerosis Anti-CD20 (Ocrelizumab) Therapy Inducing Hypogammaglobulinemia”. Translation: The University of Toledo Journal of Medical Sciences, vol. 11, no. 3, Dec. 2023, doi:10.46570/utjms.vol11-2023-836.